Liminal BioSciences Inc. LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc. > Interesting early volume

<< Previous

Bullboard Posts

Next >>

Comment by GunnerGon May 26, 2020 1:41pm

91 Views

Post# 31073918

RE:RE:RE:Interesting early volume

Thought I would repost this before you know who talks about the NAS SP increase again.

GunnerG wrote: Do a bit of research before pumping your BS. NAS was simply catching up to TSX as either exchange can go 30 to 45 miin with no trading; which is what happened.

The close on the NAS yesterday was ~7.5% less than on the TSX.

TSX last trade of the day was at 3:32 and on the NAS, a lower closing trade, at 4:00. Today they are just catching up, no mystery on the price increase.

foofadooo wrote: You got that right....NAS...volume and price increase greater than Canada.....Hybridian predicted early on .....completion of any 2 would drive the value.....Ryplazim and ???.

foof